Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-21

FDA Approved: FOSFOMYCIN TROMETHAMINE — Original Application (Kesin Pharma Corporation)

View source ↗

Summary

The FDA approved Kesin Pharma Corporation's original ANDA for fosfomycin tromethamine, authorizing the marketing of a generic antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSFOMYCIN TROMETHAMINE (FOSFOMYCIN TROMETHAMINE)

Snippet

ORIG AP for FOSFOMYCIN TROMETHAMINE (FOSFOMYCIN TROMETHAMINE)